How many insider declarations has Puissance Capital Management LP filed?

Puissance Capital Management LP has filed 1 public insider declaration with SEC (Form 4).

What is Puissance Capital Management LP's role?

Puissance Capital Management LP's reported role is not specified by the regulator across the filings.

Which companies does Puissance Capital Management LP report trades for?

Puissance Capital Management LP reports trades for Bellerophon Therapeutics, Inc..

What is Puissance Capital Management LP's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 106k€.

← Executives ★ Sign in to follow

PC

Puissance Capital Management LP

·SEC (Form 4)

Bellerophon Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€106,082

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Puissance Capital Management LP. Insider active across 1 company, notably Bellerophon Therapeutics, Inc.. Aggregated, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €106k. History available since 13 October 2023. The latest transaction was disclosed on 13 October 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Puissance Capital Management LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Bellerophon Therapeutics, Inc. (US)

申报1 总计

▼

Puissance Capital Management LP

高管2023年10月13日Bellerophon Therapeutics, Inc.

US$111,77610SEC ↗

1,076,841 股@ US$0.1038100.0% 占其流量Common StockSEC:0001760460-23-000008:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PC

Puissance Capital Management LP

·SEC (Form 4)

Bellerophon Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€106,082

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Puissance Capital Management LP. Insider active across 1 company, notably Bellerophon Therapeutics, Inc.. Aggregated, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €106k. History available since 13 October 2023. The latest transaction was disclosed on 13 October 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.